Anatomofisiología y fisiopatología de la osteoporosis
Palabras clave:
osteoporosis, remodelación óseaResumen
Se realiza una revisión bibliográfica en la que se describe la Anatomofisiología ósea en la osteoporosis. Basándonos en los conocimientos más actuales de la fisiología normal y patológica. Exponiendo los factores que influyen en la consecución de un pico de masa ósea adecuada, regulación de la resorción ósea, de la formación ósea y del remodelado óseo. Incluyendo los marcadores bioquímicos del remodelado óseo y la patogenia de la enfermedad. Para ello se utilizaron las bases de datos MEDLINE, EBSCO, HOST, DOYMA y la Literatura internacional de Medicina de los años 1989 hasta la fecha; también se incluyen algunos clásicos de la temática, localizados en los órganos de información del Sistema Nacional de Ciencias Médicas.
Descargas
Citas
NIH Consensus Stratement. Osteoporosis prevention, diagnosis, and therapy. 2000 Disponible en: http://odp.od.nih.gov/consensus/cons/111/111_statement.htm Acceso :17
enero 2005.
Melton LJ, Kan SH, Frye MA, Wahner HW, O´Fallon WM, Riggs BL. Epidemiology of vertebral fractures in wome. Am J Epidemiol 1989; 129: 1000-11.
Eddy D, Johnston CC, Cummings SR. Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Osteoposos Int 1998; 8 (Suppl 4): 1-88.
Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med 1993; 94: 646-50.
World Health Organitation. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva: Worl Health Organitation; 1994 (WHO Technical Report Series 843).
Diaz Curiel M, Carrasco de la Peña JL, Honorato Perez J, Perez Cano R, Rapado A, Ruiz Martínez I. Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Osteoporosis Int 1997; 7: 59-64.
Lawrence G, Raisz MD, Gideon A, Roldan. Pathogenesis of osteoporosis. Endocrinol Metab Clin N Am 2003; 32: 15-24.
Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res 1992; 7: 137-45.
Jergas M, Breitenseher M, Gluer CC, Yu W, Genant HK. Estimates of volumetric bone density from projectional measurements improve the discriminatory capability of dual Xray absortiometry. J Bone Miner Res 1995; 10: 1101-10.
Hangartner TN, Gilsanz V. Evaluation of cortical bone by computed tomography. J Bone Miner Res 1996; 11; 1518-25.
Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC, et al. Longitudinal monitoring of bone mass acculation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992; 75: 1060-5.
Mosekilde L. Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone. 1999; 11: 67-73.
Recker RR, Davies KM, Hinders SM, Heaney RP, Stegman MR, Kimmel DB. Bone gain in young adult women. JAMA 1998; 268: 2403-8.
Katzman DK, Bachrach LK, Carter DR, Marcus R. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 1991; 73: 1332-9.
Mora S, Gilsanz V. Establishment of peak bone mass. Endocrinol Metab Clin N Am 2003; 32: 39-63.
Carter DR, Van der Meulen MCh, Beaupre GS. Skeletal development: mechanical consequences of growth, aging and disease. En: Marcus R. Feldman D, Kelsey J, editors. Osteoporosis. San Diego: Academic Press; 1996.p. 333-50.
Peacock M, Turner ChH, Econs MJ, Foroud T. Genetics of osteoporosis. Endocr Rev 2002; 23: 303-26.
Gilsanz V, Skaggs DL, Kovanlikaya A, Sayre J, Loro ML, Kaufman F, et al. Differential effect of race on the axial and appendicular skeletons in children. J Clin Endocrinol Metab 1998; 83: 1420-7.
Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J et al. Effect of testosterona and estradiol in a man with aromatasa deficiency. N Engl J Med 1997; 337: 91-5.
Khosla S. The OPG/RANKL/RANK system. Endocrinology 2001; 142: 5050-5.
Riggs BL, Sundeep K, Melton III J. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002; 23: 279-302.
Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, Lacroix AZ, et al.
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002; 112: 281-9.
Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblast by PPAR?
, a lipid activated transcription factor. Cell 1994; 79: 1147-56.
Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PW, et al. Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 1998; 83: 4257-62.
Canalis E, Economides AN, Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 2003; 24: 218-35.
Manolagas SC. Birth and death of bone cells: basic regulatory mechanism and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000; 21:115-37.
Frost HM. Perspective on the estrogen-bone relationship and postmenopausal bone loss. J Bone Miner Res 1999; 14: 1473-7.
Seibel MJ. Biochemical markers of bone remodeling. Endocrinol Metab Clin N Am 2003: 32: 83-113.
American Association of Clinical Endocrinologist. Medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract 2001; 7: 293-312.
Heaney RP. Pathophysiology of osteoporosis. Endocrinol Metab Clin North Am 1998; 27: 255-65.
Kanis JA, Melton LJ, Christiansen C. The diagnosis of osteoporosis. J Bone Min Res 1994; 9: 1137-41.
Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1999; 332: 305-11.
Marcus R. The nature of osteoporosis. J Clin Endocrinol Metab 1999; 81: 1-5.
Riggs BL, Melton LJ. Involutional osteoporosis. N Engl J Med 2000; 314: 1676-86.
Riggs BL, Khosla S, Melton LJ. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Min Res 1998; 13: 763-73.
Rodan GA. Control of bone formation and resorption: biological and clinical perspective. J Cell Biochem 1998 Suppl; 55-61.
Rosen CJ, Kessenich CR. The pathophysilogy and treatment of postmenopausal osteoporosis: an evidence-based approach to estrogen replacement therapy. Endocrinol Metab Clin North Am 1997; 26: 295-311.
